U.S. telehealth upstart plans to sell generic Ozempic in Canada as patent due to lapse

financialpost.com/news/generic-ozempic-could-come-to-canada

U.S. telehealth upstart









Hims & Hers Health, Inc. is planning to enter the Canadian market with an eye to selling generic semaglutide, the anti-diabetic medication used for the treatment of type 2 diabetes that is growing popularity as an anti-obesity medication.

This story appeared on financialpost.com, 2025-07-09 17:59:59.
The Entire Business World on a Single Page. Free to Use →